Skip to content

Growth-Hormone & Endocrine Peptide Research

CJC-1295 DAC vs No DAC: What’s the Difference?

CJC-1295 with DAC and products called CJC no DAC differ mainly in albumin-binding design, duration and terminology around Modified GRF 1-29.

Evidence status

Human pharmacodynamic evidence exists for CJC-1295 with DAC; terminology around no-DAC materials requires careful distinction.

What is CJC-1295?

CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone investigated for GH and IGF-1 signalling.

What does DAC mean?

DAC means Drug Affinity Complex, an albumin-binding modification designed to extend biological duration.

CJC-1295 with DAC

The original CJC-1295 compound included DAC and has controlled human pharmacodynamic research.

CJC-1295 without DAC

CJC no DAC usually refers online to shorter-acting GHRH analogues, but the exact molecule should be confirmed.

Modified GRF 1-29 terminology

Modified GRF 1-29 is often used for a shorter-acting GHRH analogue and overlaps with no-DAC terminology online.

GHRH receptor signalling

Both categories relate to pituitary GHRH receptor signalling, GH pulses and downstream IGF-1 research.

Differences in biological duration

With-DAC materials are designed for longer activity, while no-DAC discussions usually involve shorter exposure.

Published human evidence

Human pharmacodynamic evidence exists for CJC-1295 with DAC. No-DAC evidence depends on the exact material.

FAQs

What does DAC mean in CJC-1295?

Drug Affinity Complex.

Is CJC no DAC the same as Mod GRF 1-29?

The terms often overlap online, but sequence confirmation matters.

Scientific references

Scientific references should be checked against primary literature and review articles for the exact compound, model and endpoint being discussed. This article avoids converting cellular or animal findings into human efficacy claims.